Hints and tips:
...Loxo’s medicine is being developed for patients whose tumours have a specific genetic defect, and is being trialled in a broad range of cancers including lung, colon and melanoma....
...Elsewhere, Swiss pharmaceuticals group Roche fell sharply after a late stage trial of its cancer drug Avastin showed that it did not prevent colon cancer in early stage sufferers....
International Edition